Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer 

BACKGROUND: The expression level of the programmed cell death ligand 1 (PD-L1) appears to be a predictor for response to immunotherapy using checkpoint inhibitors in patients with non-small cell lung cancer (NSCLC). As differences in terms of PD-L1 expression levels in the extracranial primary tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Meißner, Anna-Katharina, Gutsche, Robin, Galldiks, Norbert, Kocher, Martin, Jünger, Stephanie T., Eich, Marie-Lisa, Nogova, Lucia, Araceli, Tommaso, Schmidt, Nils Ole, Ruge, Maximilian I., Goldbrunner, Roland, Proescholdt, Martin, Grau, Stefan, Lohmann, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393847/
https://www.ncbi.nlm.nih.gov/pubmed/37382806
http://dx.doi.org/10.1007/s11060-023-04367-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393847/
https://www.ncbi.nlm.nih.gov/pubmed/37382806
http://dx.doi.org/10.1007/s11060-023-04367-7

Ejemplares similares